Presenting at EMBO Workshop Cellular signalling and cancer therapy, 14 – 18 September 2018

Our Research Scientist Dr. Nader Al-Nakouzi, will present new exciting data on oncofetal Chondrotin sulfat A in prostate cancer at the Cellular signalling and cancer therapy EMBO workshop, taking place in Cavtat, Croatia 14-18 September 2018. 

...
Continue reading

Nordic Life Science Days 2018

VAR2 Pharmaceuticals/VarCT Diagnostics will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.

Continue reading

A study further supporting rVAR2 as a potentially universal cancer targeting molecule published in Nature Communications

Today our researchers at Copenhagen University and University of British Columbia together with academic partners in United Kingdom, Australia and Taiwan published an article in Nature Communications that demonstrates that rVAR2 indeed can be used as a tool to capture and isolate circulating tumour ......
Continue reading

VAR2 Pharmaceuticals featured in Medwatch.dk

Check out the article about VAR2 Pharmaceuticals and VarCT Diagnostics here.

Continue reading